Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Public ClinicalTrials.gov record NCT00224068. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Controlled Prospective Trial of the Safety and Efficacy of Ferrlecit® in Anemic Cancer Patients Who Are Receiving Acute Chemotherapy and Epoetin as Compared to Oral Iron and No Treatment
Study identification
- NCT ID
- NCT00224068
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Watson Pharmaceuticals
- Industry
- Enrollment
- 180 participants
Conditions and interventions
Conditions
Interventions
- Sodium ferric gluconate, ferrous sulfate, standard of care Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2002
- Primary completion
- Nov 30, 2003
- Completion
- Nov 30, 2003
- Last update posted
- Mar 1, 2012
2002 – 2003
United States locations
- U.S. sites
- 32
- U.S. states
- 22
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Bakersfield | California | — | — |
| Not listed | Chula Vista | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Norwich | Connecticut | — | — |
| Not listed | Port Saint Lucie | Florida | — | — |
| Not listed | Zephyrhills | Florida | — | — |
| Not listed | Columbus | Georgia | — | — |
| Not listed | Coeur d'Alene | Idaho | — | — |
| Not listed | Hutchinson | Kansas | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Baton Rouge | Louisiana | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Detroit | Michigan | — | — |
| Not listed | Saint Joseph | Michigan | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | Duluth | Minnesota | — | — |
| Not listed | Greenwood | Mississippi | — | — |
| Not listed | Cherry Hill | New Jersey | — | — |
| Not listed | Denville | New Jersey | — | — |
| Not listed | Manhasset | New York | — | — |
| Not listed | Bismarck | North Dakota | — | — |
| Not listed | Columbus | Ohio | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | West Chester | Pennsylvania | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Laredo | Texas | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Salem | Virginia | — | — |
| Not listed | Walla Walla | Washington | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00224068, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00224068 live on ClinicalTrials.gov.